SAN DIEGO, March 17, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (SRNEQ) (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat ...
SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, ...
Get the latest news on Sorrento Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Sorrento Therapeutics performance ...
--Sorrento Therapeutics, Inc. announced today positive Phase 2 a top-line clinical trial results for the RTX program. The Phase 2 a study follows the positive observations from the Phase 1 b/2 trial ...
Some companies favor a "do one job and do it well" approach. However, that is not the Sorrento Therapeutics (SRNE) way. While being laser-focused on just one objective can have its advantages, having ...
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento ...
Police fired warning shots and tear gas as part of a dispute in northeastern Congo over the burial of a suspected Ebola victim, a footballer who played for local teams, that saw protesters burn down ...
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results